In PET, radio nuclides, typically fluorine-18, carbon-11, nitrogen-13 and oxygen-15 are incorporated into substances such as glucose or carbon dioxide to produce radiopharmaceuticals such as FDG (Fluoro-Deoxy-Glucose) which are ingested by the patient.